Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

View source ↗

Summary

This clinical trial update describes an observational study assessing general health and quality of life in retinoblastoma survivors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Retinoblastoma | Status: ACTIVE_NOT_RECRUITING